Multistate salmonella outbreak linked to recalled frozen sprouted beans: CDC, FDA
Since last fall, 11 people have been diagnosed with salmonella, data from the Centers for Disease Control and Prevention shows, with most of the cases occurring since early April. According to the CDC, Massachusetts has seen two cases in connection with this outbreak. Connecticut, Florida, Illinois, Minnesota, New Jersey, Pennsylvania, Tennessee, Virginia, and Washington have all recorded single cases.
Patients range in age from less than a year old to 78 years old, and many of them said they had shopped at Indian grocery stores and consumed Indian cuisine. Four said they ate or likely ate sprouted beans.
Which companies have agreed to drop artificial food dyes?
The CDC said testing done by the Food and Drug Administration in May revealed samples of frozen sprouted mat, or moth, and moong beans tested positive for the same salmonella strain found in those who became ill.
'This means that people likely got sick from eating sprouted beans,' the CDC explained.
Which products have been recalled?
On Wednesday, Chetak LLC Group issued a recall for packages of Deep brand frozen Sprouted Mat (Moth) and Sprouted Moong. Both products were sold in 16-ounce pouches, the notice on the FDA website reads. Impacted packages will have one of the following lot codes printed on the back of the bag:
Sprouted Mat (Moth): 24330, 25072, 25108, 24353, 25171, 24297, 25058, 25078, 24291, 25107, 24354, 24292
Sprouted Moong: 24330, 25072, 25108, 24353, 25171, 24297, 25058, 25078, 24291, 25107, 24354, 24292
The company said that while 'no illness have been reported to date in connection with this problem to company,' the sprouted beans were recalled over potential salmonella contamination that 'was noted after routine testing by FDA.' Meanwhile, an investigation into 'the source of the problem' is ongoing.
If you have any of the recalled product, you are asked to return it for a full refund.
What is salmonella?
It's caused by the salmonella bacteria, which the CDC estimates cause 1.35 million infections, 26,500 hospitalizations, and 420 deaths in the U.S. yearly.
Salmonella infections are commonly associated with diarrhea, fever and stomach cramps, according to the CDC. Symptoms can begin between six hours and six days after you've ingested the bacteria. Most people can recover without receiving treatment within four to seven days.
Illnesses may be more severe for young children, the elderly and those with weakened immune systems. Some may require medical treatment or hospitalization, the CDC explains. Infections can only be diagnosed with a laboratory test of a person's stool, body tissue or fluids.
Other recent salmonella outbreaks have been linked to pistachio cream, eggs, and cucumber products.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Gizmodo
21 minutes ago
- Gizmodo
Restaurant Unknowingly Laces Pizza With THC, Doses Nearly 100 Customers
Dozens of restaurant goers in Wisconsin had the sort of meal you wouldn't ever forget. A recent case report details how they were accidentally fed food made with tetrahydrocannabinol (THC), the primary ingredient in cannabis responsible for getting you high. Local health officials described the sitcom-like shenanigans in a report published Thursday in the CDC's Morbidity and Mortality Weekly Report. Nearly 100 customers ate the restaurant's THC-laced food in late October, some of whom visited the hospital as a result. The source of the 'outbreak' was eventually traced back to THC-infused cooking oil mistaken for ordinary canola oil. 'Clinicians and public health practitioners should be alert to the possibility of mass THC intoxication events via food,' the report authors, from Public Health Madison & Dane County, wrote. Animals Are Consuming More Alcohol Than We Realized According to the report, the trouble (or fun, depending on your perspective) began sometime on October 22. Over the next three days, at least 85 people between the ages of 1 and 91 became intoxicated shortly after eating at the restaurant, including seven people who were sent to a local hospital with symptoms like dizziness, sleepiness, and anxiety. One individual was advised to call Public Health Madison & Dane County; the person reported they had tested positive for THC without any known exposure and that they had eaten at the restaurant the day before, prompting further investigation. On October 24, officials contacted the restaurant's owner, who agreed to immediately shut the place down. That same day, the owner called back and reported that the restaurant was in a building with a cooperative (shared) kitchen used by another business that produced THC edibles derived from hemp. The owner also reported that on October 22, the restaurant ran out of its cooking oil and began using oil from the shared kitchen—which the owner assumed was simply canola oil—to make the dough for its pizzas, sandwiches, and other bread-filled goods. A large oil container in the same area where the borrowed oil was found was then tested and found positive for THC. Health officials brought in the local police for help, who determined that the restaurant's THC contamination was indeed an accident, and no criminal charges were filed against the owner or others. It also appears no one was seriously hurt as a result. After a thorough cleaning, the restaurant opened back up on October 26. Smoking Weed and Eating Edibles Share This Surprising Health Risk As funny as all this sounds, anyone who's mistakenly bitten into an edible or knows someone who has (ahem) can attest that it isn't always a picnic to deal with, even if the effects are ultimately temporary. The victims also included eight children, three who experienced vomiting and one who even developed hallucinations. Thankfully, none of them were hospitalized. The report authors say more should be done to prevent these sorts of incidents, given the rising popularity of THC and cannabis-centered businesses, especially if the businesses share space with restaurants. 'Regulations regarding practices such as standard, clear labeling and locked storage for ingredients containing THC, might decrease the risk for unintentional THC exposure at licensed food businesses,' they wrote. Personally, I'm just wondering if the incident lowered or boosted the restaurant's Yelp rating.
Medscape
21 minutes ago
- Medscape
EMA OKs Oral Treatment for Postnatal Depression
The Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA) has adopted a positive opinion on zuranolone (Zurzuvae, Biogen Netherlands BV), the first oral drug to treat postpartum depression in adults. Marketing authorization was granted in recognition of clinical trial results showing a reduction in postpartum depressive symptoms after 2 weeks' treatment. Zuranolone is a neuroactive steroid that enhances the activity of the neurotransmitter gamma-aminobutyric acid (GABA). It is thought to exert antidepressant effects by enhancing GABAergic inhibition. In a multicenter, randomized, double-blind, placebo-controlled study, zuranolone at a 50 mg dose was given for 14 days to women who met the Diagnostic and Statistical Manual of Mental Disorders criteria for a major depressive episode of postpartum depression and whose symptoms started in the third trimester or within 4 weeks of delivery. Compared with placebo, the active group demonstrated significantly greater symptom improvement on days 3,15 (the primary endpoint), and 45, using the standard 17-item Hamilton rating scale for depression. The FDA approved the drug in August 2023, at which time it was the first oral treatment for postpartum depression, with previous therapies requiring intravenous dosing. It is available in 20 mg, 25 mg, and 30 mg capsules. The most common side effects are somnolence, dizziness, confusion, trouble walking, and sedation. Patients are advised to avoid alcohol and not to drive, operate machinery, or undertake other dangerous activities until at least 12 hours after taking each dose during the 14-day treatment course. There may also be an increased risk of suicidal thoughts and actions in people 24 years of age and younger. Animal studies have suggested a possible risk of teratogenic effects, so women who may become pregnant are advised to use effective contraception during treatment and for 1 week after the final dose, and to alert their healthcare provider should they become pregnant during treatment. The EMA said that detailed recommendations will be described in the summary of product characteristics, which will be published on the EMA website in all official European Union languages after the marketing authorization has been granted by the European Commission. Perinatal Mental Healthcare 'in Its Infancy' In Western countries, postpartum depression is estimated to affect between 10% and 15% of women during the first year after birth , with substantial differences in rates depending on socioeconomic factors such as marital status, educational level, social support, spouse care, violence, gestational age, breast feeding, child mortality, financial difficulties, partnership, life stress, smoking, alcohol intake, and living conditions. Common symptoms include feelings of desperation, sadness, anxiety, irritability, and isolation, as well as nausea, changes in sleep and eating habits, decreased libido, crying spells, mental lability, thoughts of hurting oneself and/or the infant, and suicidal ideation. The condition can wreak havoc on women's mental health as well as that of their partners. It can impair the parental relationship, the mother-child bond, and the emotional and cognitive growth of infants, with potential long-term effects. Postnatal depression may occur alongside post-traumatic stress disorder following stressful or traumatic childbirth experiences . Yet a review published in Frontiers in Psychiatry last year suggested that fewer than half of countries in the World Health Organization (WHO) European region had policies specifically on perinatal mental health, leading its authors to conclude that "perinatal mental health care is in its infancy in most WHO European countries."
Time Business News
an hour ago
- Time Business News
Next-Gen Breakthroughs Transform Influenza Diagnostics
Influenza diagnostics refers to methods and devices that are used to detect influenza virus infections in individuals, including rapid antigen tests, molecular assays (such as RT-PCR), and immunoassays. The market for influenza diagnostics is increasing due to increasing global awareness about infectious diseases, increasing incidence of influenza and increasing outbreaks, increasing demand for rapid and accurate testing, increasing demand for progress in clinical technologies and further emphasis on the identity of initial diseases and the identity of early diseases by governments and healthcare organizations. Key Growth Drivers and Opportunities Global Awareness about Infectious Diseases: Global awareness about infectious diseases increases the demand for increasing, accurate, accurate and comprehensive testing. Recent experiences with epidemic such as public health campaigns, media coverage, and Covid-19 have increased the importance of the general population of viral transmission and timely diagnosis. As a result, the healthcare provider and the government are prioritizing investment in clinical infrastructure, rapid testing development and monitoring systems to prevent large -scale outbreaks. This awareness leads to maximum adoption of influenza diagnostic tools in hospitals, clinics, airports and even home settings, which promotes continuous market growth. Challenges Influenza diagnostics faces the high cost of advanced testing technologies in the market, low income and clinical equipment limited to clinical equipment in rural areas and the limits of variability in test accuracy-especially with antigen tests that may be false negative. Additionally, the seasonal nature of influenza may demand ups and downs, affecting continuous revenue creation and investment. Regulatory obstacles and skilled personnel need to be widely adopted to adopt molecular diagnosis. Innovation and Expansion Quest Diagnostics Gets CDC Contracts to Create Oropouche Virus and H5 Avian Flu Tests In October 2024, leading diagnostic information services provider Quest Diagnostics announced that the U.S. Centers for Disease Control and Prevention (CDC) has awarded it multiple contracts to support testing and ongoing laboratory readiness for two newly discovered infectious diseases in the Americas. By guaranteeing that a national commercial laboratory provider may promptly augment public health laboratories in the case of an infectious disease epidemic in humans, the agreements will enhance the country's readiness for avian influenza and Oropouche viruses. The FDA Approves the First Over-the-Counter Flu and COVID-19 Test at Home In February 2023, the first over-the-counter (OTC) at-home diagnostic test that can distinguish and identify influenza A and B, sometimes referred to as the flu, and SARS-CoV-2, the virus that causes COVID-19, was granted an emergency use authorization (EUA) by the U.S. Food and Drug Administration. A single-use at-home test kit, the Lucira COVID-19 & Flu Home Test yields findings from self-collected nose swab samples in around half an hour. A single-use test for those exhibiting symptoms and indicators typical of a respiratory tract infection, including COVID-19, is the Lucira COVID-19 & Flu Home Test. The test is available without a prescription and may be done entirely at home with nose swab samples that people 14 years of age or older self-collect. Inventive Sparks, Expanding Markets Investing in major development strategies for influenza diagnostics manufacturers, investing rapidly and in multiplex test technologies, expanding at home and point-of-care test offerings, forming partnership with healthcare providers and governments, securing regulatory approval quickly and strengthening the global distribution network-in special emergence markets. About Author: Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business. TIME BUSINESS NEWS
